pvl3bzlo

Property	Value
?:abstract	ABSTRACT Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO) Advanced age and comorbid disease, well-known characteristics in the solid tumor population, have been reported as risk factors for severe disease and death Cancer-related immunosuppression and its treatments also seem to play an active role in the prognosis, response, and clinical outcomes of these patients The most effective combination therapy for COVID-19 is still under investigation, and the use of corticosteroids is controversial Although, as a group, metastatic cancer patients are often considered not to be good candidates for ICU treatment, the individual prognosis should always come into consideration, even in a context of high pressure on medical facilities We report the case of a stage IV prostate cancer patient infected with SARS-CoV-2 who required ICU admission and recovered from COVID-19 infection Further studies are needed in order to identify accurate clinical prognostic criteria and provide the best treatment for these challenging patients Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO). Advanced age and comorbid disease, well-known characteristics in the solid tumor population, have been reported as risk factors for severe disease and death. Cancer-related immunosuppression and its treatments also seem to play an active role in the prognosis, response, and clinical outcomes of these patients. The most effective combination therapy for COVID-19 is still under investigation, and the use of corticosteroids is controversial. Although, as a group, metastatic cancer patients are often considered not to be good candidates for ICU treatment, the individual prognosis should always come into consideration, even in a context of high pressure on medical facilities. We report the case of a stage IV prostate cancer patient infected with SARS-CoV-2 who required ICU admission and recovered from COVID-19 infection. Further studies are needed in order to identify accurate clinical prognostic criteria and provide the best treatment for these challenging patients.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C0006826> <https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C0027627> <https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C0278837> <https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C0279068> <https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C1373218> <https://research.tib.eu/covid-19/entity/pvl3bzlo_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Parmanande%2C_Anuraj%3B_Sim%C3%A3o%2C_Diana%3B_Sardinha%2C_Mariana%3B_Reis%2C_Ana_Filipa_Palma_dos%3B_Spencer%2C_Ana_Sofia%3B_Barreira%2C_Jo%C3%A3o_Vasco%3B_Luz%2C_Ricardo_da> <https://research.tib.eu/covid-19/entity/Parmanande%2C_Anuraj_Sim%C3%A3o_Diana_Sardinha_Mariana_Reis_Ana_Filipa_Palma_dos_Spencer_Ana_Sofia_Barreira_Jo%C3%A3o_Vasco_Luz_Ricardo_da>
?:journal	Autops._Case_Rep
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/pvl3bzlo_HAS_C5203670_INTERACTS_WITH_C5203676>
?:source	WHO
?:title	Full recovery of a stage IV cancer patient facing COVID-19 pandemic
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#742659 #940305
?:year	2020

Property

Value

?:abstract

ABSTRACT Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO) Advanced age and comorbid disease, well-known characteristics in the solid tumor population, have been reported as risk factors for severe disease and death Cancer-related immunosuppression and its treatments also seem to play an active role in the prognosis, response, and clinical outcomes of these patients The most effective combination therapy for COVID-19 is still under investigation, and the use of corticosteroids is controversial Although, as a group, metastatic cancer patients are often considered not to be good candidates for ICU treatment, the individual prognosis should always come into consideration, even in a context of high pressure on medical facilities We report the case of a stage IV prostate cancer patient infected with SARS-CoV-2 who required ICU admission and recovered from COVID-19 infection Further studies are needed in order to identify accurate clinical prognostic criteria and provide the best treatment for these challenging patients
Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO). Advanced age and comorbid disease, well-known characteristics in the solid tumor population, have been reported as risk factors for severe disease and death. Cancer-related immunosuppression and its treatments also seem to play an active role in the prognosis, response, and clinical outcomes of these patients. The most effective combination therapy for COVID-19 is still under investigation, and the use of corticosteroids is controversial. Although, as a group, metastatic cancer patients are often considered not to be good candidates for ICU treatment, the individual prognosis should always come into consideration, even in a context of high pressure on medical facilities. We report the case of a stage IV prostate cancer patient infected with SARS-CoV-2 who required ICU admission and recovered from COVID-19 infection. Further studies are needed in order to identify accurate clinical prognostic criteria and provide the best treatment for these challenging patients.

is ?:annotates of